Regent Pacific Group Limited (HKG:0575)

Market Cap	277.22M
Revenue (ttm)	5.58M
Net Income (ttm)	-34.81M
Shares Out	291.82M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,783
Average Volume	73,960
Open	0.9100
Previous Close	0.9200
Day's Range	0.9100 - 0.9500
52-Week Range	0.3200 - 1.2400
Beta	1.06
RSI	50.17
Earnings Date	Aug 26, 2025

About Verve Therapeutics

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.